RAPT Therapeutics, Inc. (RAPT) NASDAQ

1.15

+0.035(+3.15%)

Updated at February 05 01:58PM

Currency In USD

Valuation

Market Cap952.7M
Enterprise Value912.13M
P/E Ratio-0.4
PEG Ratio-0.04
Price/Sales Ratio27.71
Price/Book Ratio0.45
Enterprise/Revenue21.51
Enterprise/EBITDA-1

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-20.33
Operating Margin-21.72

Management Effectiveness

Return On Assets-0.99
Return On Equity-0.89

Income Statement

Revenue0
Revenue/Share0.14
Gross Profit-3.55M
EBITDA-125.85M
Net Income-116.8M
Diluted EPS-3.05

Balance Sheet

Total Cash97.91M
Total Cash/Share2.52
Total Debt5.12M
Total Debt/Equity0.05
Current Ratio9.9
Book Value Per Share2.45

Price History

52-Week Change-95.58
52-Week High27.35
52-Week Low0.79
Moving Average 50 Days1.22
Moving Average 200 Days2.76

Statistics

Average Volume3.63M
Shares Outstanding132.01M
% Held by Institutions76.6

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A